关于与供销集团财务有限公司关联存贷款的 风险持续评估报告 成立日期：2014年2月21日 企业性质：有限责任公司（法人独资） 注册地址：北京市西城区宣武门外大街甲1号C座7层 法定代表人：庄学能 注册资本：50,000万元人民币 统一社会信用代码：911100000882799490 金融许可证机构编码：L0191H211000001 经营范围：经营以下本外币业务：（一）对成员单位办理财务和融资顾问、 信用鉴证及相关的咨询、代理业务；（二）协助成员单位实现交易款项的收付； （三）经批准的保险代理业务；（四）对成员单位提供担保；（五）办理成员单位 之间的委托贷款；（六）对成员单位办理票据承兑与贴现；（七）办理成员单位之 间的内部转账结算及相应的结算、清算方案设计；（八）吸收成员单位的存款； （九）对成员单位办理贷款及融资租赁；（十）从事同业拆借。（市场主体依法自 主选择经营项目，开展经营活动；依法须经批准的项目，经相关部门批准后依批 准的内容开展经营活动；不得从事国家和本市产业政策禁止和限制类项目的经营 山东中农联合生物科技股份有限公司（以下简称"公司"）根据《深圳证券 交易所上市公司自律监管指引第 7 号-交 ...

证券代码：003042 证券简称：中农联合 公告编号：2023-030 山东中农联合生物科技股份有限公司 2023 年半年度募集资金存放与使用情况的专项报告 本公司及董事会全体成员保证公告内容真实、准确和完整，不存在任何虚假 记载、误导性陈述或者重大遗漏。 根据中国证券监督管理委员会《上市公司监管指引第2号-上市公司募集资金 管理和使用的监管要求》和深圳证券交易所《深圳证券交易所上市公司自律监管 指引第1号-主板上市公司规范运作》《深圳证券交易所上市公司自律监管指南第 2号-公告格式》等相关规定，山东中农联合生物科技股份有限公司（以下简称"公 司"）编制了截至2023年6月30日止的《2023年半年度募集资金存放与使用情况 的专项报告》（若出现合计数字与各明细数字直接相加之和尾数不符的情况，均 为四舍五入原因所致）。 一、募集资金基本情况 （一）实际募集资金金额、资金到位情况 经中国证券监督管理委员会《关于核准山东中农联合生物科技股份有限公司 首次公开发行股票的批复》（证监许可[2021]789号）核准，并经深圳证券交易所 同意，公司向社会公开发行人民币普通股（A股）2,740万股，发行价格为21.56 元/ ...

山东中农联合生物科技股份有限公司 第四届监事会第五次会议决议公告 本公司及监事会全体成员保证公告内容真实、准确和完整，不存在任何虚假 记载、误导性陈述或者重大遗漏。 证券代码：003042 证券简称：中农联合 公告编号：2023-027 （二）审议通过《关于 2023 年半年度募集资金存放与使用情况的专项报告 的议案》 经审核，监事会认为：公司 2023 年半年度募集资金存放与使用情况的专项 报告反映了公司募集资金存放与使用的实际情况，公司募集资金存放及使用符合 法律、法规、中国证监会及深圳证券交易所的相关规定，不存在违规使用募集资 金及损害股东利益的情形。 具体内容详见同日刊载于巨潮资讯网（www.cninfo.com.cn）及《上海证券报》 《证券时报》《中国证券报》《证券日报》的《2023 年半年度募集资金存放与使用 情况的专项报告》。 一、监事会召开情况 山东中农联合生物科技股份有限公司（以下简称"公司"）第四届监事会第五 次会议于 2023 年 8 月 25 日在公司会议室以现场结合通讯方式召开。会议通知已 于 2023 年 8 月 15 日通过邮件及专人送达的方式通知到各位监事。本次会议应出 席监 ...

证券代码：003042 证券简称：中农联合 山东中农联合生物科技股份有限公司 投资者关系活动记录表 编号：2023-001 投资者关系活动类别 ☐特定对象调研 ☐分析师会议 ☐媒体采访 业绩说明会 ☐新闻发布会 ☐路演活动 ☐现场参观 ☐其他（请文字说明其他活动内容） 参与单位名称及人员姓名 线上参与公司2022年度暨2023年第一季度网上业绩说明会的全体投 资者 时间 2023年05月08日 15:00-16:30 地点 价值在线（https://www.ir-online.cn/）网络互动 董事、总经理 许辉 独立董事 王贡勇 董事会秘书 颜世进 上市公司接待人员姓名 财务总监 李强 保荐代表人 胡亦非 投资者关系活动主要内容 1.市值什么时候能到千亿 答:尊敬的投资者您好,感谢您对公司的期望，公司将按照农药 绿色发展和高质量发展的总体要求,继续加大科研投入，实现从仿 制为主到仿创结合转变；生产体系持续进行工艺优化、技术改造， 介绍 逐步完成自动化、智能化改造,实现精细化管理；加强创新农业服 务体系及自我品牌建设，完善与建立适合国内、国外两个市场发展 的营销服务体系；逐步完善并优化产品布局、丰富产品类别， ...

Financial Performance - The company's revenue for Q1 2023 was CNY 504,847,216.52, representing a 20.48% increase compared to CNY 419,024,555.20 in the same period last year[5]. - Net profit attributable to shareholders decreased by 28.88% to CNY 17,020,776.89 from CNY 23,934,028.38 year-on-year[5]. - Basic and diluted earnings per share fell by 29.41% to CNY 0.12 from CNY 0.17 in the same quarter last year[5]. - Net profit for the current period was ¥17,020,776.89, a decrease of 28.6% from ¥23,934,028.38 in the same period last year[18]. - The total profit for the current period was ¥21,868,813.49, down 22.5% from ¥28,083,118.93 in the previous period[18]. Cash Flow and Operating Activities - The net cash flow from operating activities improved significantly, with a net outflow of CNY -9,493,741.31, an 87.68% reduction from CNY -77,047,987.38 in the previous year[5]. - The company reported a net cash outflow from operating activities of ¥9,493,741.31, an improvement from a net outflow of ¥77,047,987.38 in the previous period[21]. - The company experienced a net cash outflow from investing activities of ¥47,350,177.04, compared to a net outflow of ¥77,265,789.51 in the previous period[21]. Assets and Liabilities - Total assets decreased by 6.74% to CNY 3,298,406,922.37 from CNY 3,536,777,640.77 at the end of the previous year[5]. - The company's current assets decreased to CNY 1,394,651,793.81 from CNY 1,668,184,086.58, indicating a reduction of approximately 16.4%[14]. - Total liabilities decreased to CNY 1,601,176,888.06 from CNY 1,857,601,706.62, a reduction of about 13.8%[15]. - The company's cash and cash equivalents decreased to CNY 275,173,482.32 from CNY 315,811,223.45, a decline of approximately 12.8%[14]. - Cash and cash equivalents at the end of the period were ¥88,284,925.48, down from ¥393,182,892.99 at the end of the previous period[22]. Operating Costs and Expenses - The company's operating costs increased by 34.10% to CNY 407,577,857.07, attributed to higher sales volume[8]. - Total operating costs amounted to ¥486,157,241.50, up 24.5% from ¥390,514,147.55 in the prior period[17]. - Financial expenses rose by 62.27% to CNY 9,176,002.95 due to increased exchange losses during the reporting period[8]. - The company incurred financial expenses of ¥9,176,002.95, which is an increase of 62.5% from ¥5,654,664.18 in the previous period[17]. - Research and development expenses for the current period were ¥14,087,986.10, a decrease of 15.2% compared to ¥16,600,512.51 in the prior period[17]. Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 28,386, with the largest shareholder holding 30.57% of the shares[10]. - The company's retained earnings rose to CNY 700,240,483.07 from CNY 683,219,706.20, an increase of approximately 2.5%[15]. - The total equity attributable to the parent company increased to CNY 1,697,230,034.31 from CNY 1,679,175,934.15, reflecting a growth of about 1.1%[15]. Strategic Initiatives - The company plans to continue expanding its market presence and investing in new product development to drive future growth[5]. - The company established a wholly-owned subsidiary, Shandong Zhihui Testing Technology Co., Ltd., with a registered capital of CNY 10 million to enhance its R&D capabilities and business expansion[12]. Accounts Receivable and Inventory - Accounts receivable increased to CNY 433,894,599.45 from CNY 350,520,962.87, reflecting a growth of about 23.7%[14]. - Inventory decreased to CNY 553,910,592.15 from CNY 593,539,440.61, showing a decline of approximately 6.7%[14]. - Short-term borrowings increased to CNY 334,100,082.33 from CNY 326,029,829.51, reflecting a slight increase of about 2.3%[15].

Financial Performance - The company's operating revenue for 2022 was ¥1,933,423,776.43, representing an increase of 18.97% compared to ¥1,625,072,614.01 in 2021[18]. - The net profit attributable to shareholders decreased by 25.82% to ¥73,137,854.07 from ¥98,594,923.92 in the previous year[18]. - Basic and diluted earnings per share fell by 31.08% to ¥0.51 from ¥0.74 in 2021[18]. - Total assets increased by 9.82% to ¥3,536,777,640.77 at the end of 2022, up from ¥3,220,519,913.33 at the end of 2021[18]. - The company's net assets attributable to shareholders rose by 3.22% to ¥1,679,175,934.15 from ¥1,626,867,835.43 in the previous year[18]. - The total revenue for 2022 reached ¥1,933,423,776.43, representing an 18.97% increase compared to ¥1,625,072,614.01 in 2021[60]. - The pesticide industry contributed ¥1,803,693,481.13, accounting for 93.29% of total revenue, with a year-on-year growth of 17.88%[60]. - The company's gross profit margin decreased to 21.30% in the pesticide sector, down from 25.23% in the previous year[62]. - Domestic sales amounted to ¥1,216,289,046.51, which is 62.91% of total revenue, showing a 5.46% increase year-on-year[60]. - International sales surged by 52.01%, reaching ¥717,134,729.92, which is 37.09% of total revenue[60]. Risk Management - The company emphasizes the importance of risk awareness regarding forward-looking statements in the report, indicating potential operational risks in future developments[3]. - The company is exposed to risks from price fluctuations of its main products, which could impact its operating performance due to market supply and demand changes[107]. - Raw materials constitute a high proportion of the company's main business costs, and price fluctuations in raw materials could adversely affect profitability[108]. - The company is committed to closely monitoring raw material price trends and implementing strategies to stabilize procurement costs[108]. - There is a risk that fundraising projects may not achieve expected returns due to changes in pesticide regulations, macroeconomic conditions, and market capacity[109]. - The company is enhancing its risk management measures for fundraising projects to ensure quality and progress in implementation[110]. - The company is actively expanding into overseas markets, which exposes it to exchange rate fluctuation risks that could impact its operating performance[111]. Corporate Governance - The company has established a complete governance structure, including a shareholders' meeting, board of directors, and supervisory board, ensuring operational independence[128]. - The company has confirmed that there are no significant differences between its governance practices and the regulations set by the China Securities Regulatory Commission[123]. - The company reported a participation rate of 57.57% in the 2021 Annual General Meeting held on May 18, 2022[130]. - The company maintains independent financial management, with a dedicated finance department and independent accounting systems, ensuring no shared bank accounts with the controlling shareholder[129]. - The company has a total of 3 supervisors on the supervisory board, including 1 employee representative, complying with governance standards[120]. - The company has implemented a transparent information disclosure system, ensuring timely and accurate information release to all shareholders[121]. - The supervisory board found no risks during its oversight activities in the reporting period[161]. - The board of directors has been diligent in fulfilling its responsibilities and has contributed positively to the company's development[156]. Research and Development - The company has developed a complete pesticide production and R&D system, with 53 domestic invention patents and several international patents, indicating strong innovation capabilities[36]. - The company is focusing on expanding its market presence and developing new products in the agricultural biotechnology sector[80]. - The company is investing in new product development, with a budget allocation of 600 million RMB for R&D in 2023[134]. - The company plans to accelerate the research and development of new fungicides and herbicides, while optimizing production processes to enhance product competitiveness[101]. - The company has established cooperative relationships with several universities, enhancing its R&D capabilities[46]. - The company has a personnel management system that ensures all senior management and core technical staff are exclusively employed by the company[126]. Environmental Compliance - The company strictly complies with various environmental protection laws and standards, including the Environmental Protection Law of the People's Republic of China and the Air Quality Standards[184]. - The company has implemented a continuous monitoring system for emissions, ensuring adherence to environmental standards[187]. - The company has developed new technologies for waste gas treatment, including RTO systems, to reduce VOC emissions[189]. - The company has established a comprehensive environmental management system to monitor and control pollution sources effectively[189]. - The company aims to expand its market presence while maintaining strict environmental compliance and sustainability practices[189]. - The company has invested significantly in environmental protection facilities, ensuring that all pollutants are treated and utilized according to legal requirements, positioning its environmental investment ratio among the top in the industry[197]. Shareholder Engagement - The company has a dedicated investor relations team to handle inquiries and maintain communication with shareholders[15]. - The company actively engages with investors through various channels, including performance briefings and investor reception days[122]. - The company has established a dynamic management mechanism that allows for adjustments in employee compensation based on performance and position[164]. - The company has a total of 142,480,000 shares as the basis for its profit distribution plan[171]. - The company distributed a cash dividend of RMB 2 per 10 shares, totaling RMB 14,248,000, which represents 100% of the profit distribution[171]. Market Trends - The global pesticide market size increased from $47.171 billion in 2010 to $73.42 billion in 2021, reflecting a growing demand driven by population and food needs[29]. - China's pesticide production reached 2,498,500 tons in 2021, with a year-on-year growth of 16.3%, solidifying its position as the largest pesticide producer and exporter globally[29]. - The global agricultural pesticide market is experiencing stable demand despite rising costs due to geopolitical tensions and inflation, with a notable increase in raw material prices[31]. - The United Nations projects the world population to reach 8 billion in 2022 and 9.7 billion by 2050, leading to a growing demand for agricultural products and consequently, pesticides[32]. - Crop pests cause up to 40% of global food loss annually, costing the economy approximately $220 billion for plant diseases and $70 billion for invasive pests, highlighting the critical role of pesticides in modern agriculture[33].

（二）会议召开地点：价值在线（www.ir-online.cn） （三）会议召开方式：网络互动方式 证券代码：003042 证券简称：中农联合 公告编号：2023-003 山东中农联合生物科技股份有限公司关于 举办 2022 年度暨 2023 年第一季度网上业绩说明会的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 山东中农联合生物科技股份有限公司（以下简称"公司"）将于 2023 年 4 月 28 日在巨潮资讯网（www.cninfo.com.cn）披露《2022 年年度报告全文》《2022 年 年度报告摘要》及《2023 年第一季度报告》。为便于广大投资者更加全面深入地 了解公司经营业绩、发展战略等情况，公司定于 2023 年 5 月 8 日（星期一）15:00- 16:30 在"价值在线"（www.ir-online.cn）举办 2022 年度暨 2023 年第一季度网上 业绩说明会，与投资者进行沟通和交流，广泛听取投资者的意见和建议。具体情 况如下： 一、说明会召开的时间、地点和方式 （一）会议召开时间：2023 年 5 月 8 日（星期一）15 ...

证券代码：003042 证券简称：中农联合 编号：2022-001 山东中农联合生物科技股份有限公司 投资者关系活动记录表 | --- | --- | --- | |------------------------|---------------------------------------------------------------------------|---------------------------------------------------------| | | | | | | ☐ 特定对象调研 | ☐分析师会议 | | | ☐媒体采访 | 业绩说明会 | | 投资者关系活动类别 | ☐ 新闻发布会 | ☐ 路演活动 | | | ☐现场参观 | | | | ☐ | 其他（请文字说明其他活动内容） | | 形式 ☐ | 现场 网上 | ☐ 电话会议 | | 参与单位名称及人员姓名 | 线上参与公司 2021 者 | 年度暨 2022 年第一季度网上业绩说明会的投资 | | 时间 | 2022 年05月 10日 | 15:00-17:00 | | 地点 价值在线（ | | https:/ ...

证券代码：003042 证券简称：中农联合 公告编号：2022-063 山东中农联合生物科技股份有限公司 关于参加山东辖区上市公司 2022 年度 投资者网上集体接待日活动的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 为进一步加强山东中农联合生物科技股份有限公司（以下简称"公司"）与 广大投资者之间的沟通交流，提升公司投资者关系管理水平，保护投资者权益， 公司将于 2022 年 11 月 16 日（星期三）14:00—16:00 参加由山东证监局、山东 上市公司协会联合举办，深圳市全景网络有限公司承办的"山东辖区上市公司 2022 年度投资者网上集体接待日活动"，现将有关事项公告如下： 本次投资者网上集体接待日活动将在深圳市全景网络有限公司提供的网上 平台采取网络远程方式举行，投资者可以登录全景·路演天下（http://rs.p5w.net） 参与本次活动。公司将与投资者通过网络在线交流形式，就公司治理及社会责任 /ESG、经营情况、发展战略、风险防控、投资者保护、三季度报告等投资者所关 心的问题，通过互动平台与投资者进行"一对多"形式的沟通，搭建上 ...

Financial Performance - The company reported a total revenue of 500 million RMB for the first half of 2022, representing a year-on-year increase of 15%[14]. - The net profit attributable to shareholders reached 80 million RMB, up 20% compared to the same period last year[14]. - The company's revenue for the reporting period was ¥1,011,491,766.78, representing a 24.71% increase compared to ¥811,054,448.27 in the same period last year[20]. - Net profit attributable to shareholders was ¥41,508,643.36, an increase of 85.51% from ¥22,375,391.45 year-on-year[20]. - The total profit for the period was ¥49,009,436.00, a 94.76% increase from ¥25,163,494.71, driven by higher operating revenue and improved gross margin[55]. - The company achieved scale production of key intermediates for neonicotinoid insecticides, ensuring a stable supply for its products[48]. - The company reported a significant increase in accounts receivable, totaling ¥445,457,614, which is 12.96% of total assets, reflecting a 5.99% increase from the previous year[62]. - The company reported a significant increase in revenue, achieving a total of 1.2 billion RMB for the first half of 2022, representing a year-over-year growth of 15%[118]. - The company reported a significant decline in stock price, with a continuous drop for 20 trading days below the latest audited net asset value per share[119]. User Growth and Market Expansion - User data indicates a growth in active users by 25%, reaching 1.5 million users by the end of June 2022[14]. - The company is focusing on expanding its market presence in Southeast Asia, targeting a 20% market share by 2025[14]. - The company plans to continue expanding its market presence and investing in new product development to sustain growth[59]. - Market expansion plans include entering two new provinces, which are projected to increase market share by 5%[118]. Product Development and Innovation - The company plans to launch three new products in the second half of 2022, focusing on organic pesticides and biocontrol agents[14]. - Research and development expenses increased by 30%, totaling 50 million RMB, to support innovation and new technology development[14]. - The company is actively developing new products, including the registration of the pesticide compounds triflumuron and benzoylurea[34]. - The company has successfully developed and launched new pesticide products, including a novel compound for nematode control, enhancing its product portfolio[46]. - The company is investing 100 million RMB in research and development for new technologies aimed at enhancing product efficiency[118]. Financial Strategy and Investments - The company is exploring potential acquisitions to enhance its market position and expand its product portfolio[14]. - The company has committed to a project with an annual production capacity of 3,300 tons of pesticide raw materials, with a total investment of RMB 25,000,000.00, achieving 100% of the planned investment[78]. - The total investment amount for the reporting period was ¥220,158,085.17, representing a 48.97% increase compared to ¥150,059,326.36 in the same period last year[67]. - The company is considering strategic acquisitions to enhance its product portfolio, with a budget of 300 million RMB allocated for potential deals[118]. Risk Management - The company has identified key risks including regulatory changes and market competition, with strategies in place to mitigate these risks[14]. - The company is actively pursuing market expansion and new product development in the agricultural biotechnology sector[69]. - The company has implemented measures to mitigate risks associated with foreign exchange fluctuations, including strict management of accounts receivable and purchasing credit insurance for export payments[73]. - The company is focused on risk analysis related to derivative investments, including market price fluctuations and customer default risks[73]. Environmental and Social Responsibility - The company emphasizes safety and environmental protection, achieving recognition as a "2022 Provincial Green Factory" for its subsidiary[36]. - The company is committed to green and low-carbon development, optimizing resource utilization and maximizing efficiency[36]. - The company has increased its environmental protection investments and aims to further enhance emission reduction and environmental governance levels[85]. - The company actively engages in social responsibility initiatives, including donations to local educational and agricultural development projects[106]. Shareholder and Governance Matters - No cash dividends will be distributed for the current fiscal year, as the company aims to reinvest profits into growth initiatives[4]. - The company has committed to not transferring or entrusting the management of its shares for 36 months from the date of listing[117]. - The company will handle any rights issues or stock splits according to the regulations of the Shenzhen Stock Exchange[117]. - The company has established a profit distribution policy to enhance transparency and protect the rights of public investors[121]. Compliance and Legal Matters - The company has not experienced significant changes in accounting policies or principles compared to the previous reporting period[73]. - The company has not encountered any significant changes in the feasibility of its projects or reasons for not meeting planned progress or expected benefits[78]. - The company has fulfilled all commitments related to share management as of the reporting period[117]. - The company will ensure that the board votes in favor of refunding investors if the IPO prospectus is found to have significant issues[122].